Deutsche Bank
ZVRA icon

Deutsche Bank’s Zevra Therapeutics ZVRA Stock Holding History

Deutsche Bank’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$829K Buy
57,809
+6,436
+13% +$71.5K ﹤0.01% 2483
2026
Q1 		$479K Buy
51,373
+5,434
+12% +$49K ﹤0.01% 2590
2025
Q4 		$412K Buy
45,939
+1,936
+4% +$18.3K ﹤0.01% 2671
2025
Q3 		$418K Buy
44,003
+5,533
+14% +$55.5K ﹤0.01% 2647
2025
Q2 		$339K Sell
38,470
-7,211
-16% -$58.5K ﹤0.01% 2658
2025
Q1 		$342K Sell
45,681
-5,225
-10% -$41.5K ﹤0.01% 2683
2024
Q4 		$425K Buy
50,906
+10,306
+25% +$88K ﹤0.01% 2697
2024
Q3 		$282K Buy
40,600
+10,131
+33% +$68.8K ﹤0.01% 2750
2024
Q2 		$149K Buy
30,469
+12,846
+73% +$60.9K ﹤0.01% 2967
2024
Q1 		$102K Buy
17,623
+870
+5% +$5.35K ﹤0.01% 3161
2023
Q4 		$110K Buy
16,753
+701
+4% +$3.28K ﹤0.01% 3183
2023
Q3 		$77.4K Buy
+16,052
New +$80.1K ﹤0.01% 3272
2022
Q2 		– Sell
-15,622
Closed -$79K – 4353
2022
Q1 		$79K Sell
15,622
-1,712
-10% -$10.9K ﹤0.01% 3668
2021
Q4 		$151K Buy
17,334
+900
+5% +$8.03K ﹤0.01% 3509
2021
Q3 		$153K Sell
16,434
-2,553
-13% -$25.7K ﹤0.01% 3701
2021
Q2 		$244K Buy
+18,987
New +$204K ﹤0.01% 3673
2018
Q3 		– Sell
-3,438
Closed -$358K – 5586
2018
Q2 		$358K Buy
3,438
+2,590
+305% +$253K ﹤0.01% 4018
2018
Q1 		$107K Buy
848
+840
+10,500% +$81.2K ﹤0.01% 4471
2017
Q4 		$0 Buy
+8
New +$483 ﹤0.01% 5171
2017
Q2 		– Sell
-96
Closed -$7K – 5146
2017
Q1 		$7K Buy
96
+56
+140% +$3.4K ﹤0.01% 4662
2016
Q4 		$1K Sell
40
-219
-85% -$13.4K ﹤0.01% 4852
2016
Q3 		$18K Sell
259
-92
-26% -$6.54K ﹤0.01% 4560
2016
Q2 		$21K Sell
351
-394
-53% -$64.8K ﹤0.01% 4739
2016
Q1 		$172K Buy
745
+424
+132% +$103K ﹤0.01% 3731
2015
Q4 		$102K Buy
+321
New +$87.1K ﹤0.01% 4048

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

Deutsche Bank's ZVRA Position: Q2 2026 in Review

Deutsche Bank increased its Zevra Therapeutics (ZVRA) stake by 13% in Q2 2026, buying an estimated $71.5K and bringing the position to 57,809 shares worth $829K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

Deutsche Bank first reported a position in ZVRA in Q4 2015 and has held it in 25 quarters since. 54 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Deutsche Bank held 57,809 shares of Zevra Therapeutics worth $829K as of Q2 2026.
  • Deutsche Bank bought 6,436 Zevra Therapeutics shares in Q2 2026, an estimated $71.5K.
  • Zevra Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2483 holding.
  • Deutsche Bank first reported a position in Zevra Therapeutics in Q4 2015 and has held it in 25 quarters since.
  • 54 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.